Neuropeptide Y: Some viewpoints on a multifaceted peptide in the normal and diseased nervous system

Brain Research Reviews

Volumn 26, Issue 2-3, 1998, Pages 154-166

  Hokfelt T ^a   Broberger, C ^a   Zhang, X ^a,b   Diez, M ^a   Kopp, J ^a   Xu, Z Q ^a   Landry, M ^a   Bao, L ^b   Schalling, M ^c   Koistinaho, J ^a,d   DeArmond, S J ^e   Prusiner, S ^e   Gong, J ^b   Walsh, J H ^f  

^a KAROLINSKA INSTITUTE   (Sweden)

^b Department of Neurobiology ^*  (China)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d UNIVERSITY OF EASTERN FINLAND   (Finland)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Anorexia; Cerebral blood vessels; Dorsal root ganglia; Food intake; Neurotransmitters; Prion

Indexed keywords

NEUROPEPTIDE Y;

ANIMAL TISSUE; BRAIN DISEASE; BRAIN REGION; CONFERENCE PAPER; CONTROLLED STUDY; DIAGNOSTIC VALUE; IN SITU HYBRIDIZATION; MONKEY; NERVE INJURY; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION;

EID: 0032077719     PISSN: 01650173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0173(97)00052-0     Document Type: Conference Paper

References (132)

1. Abe M., Saito M., Ikeda H., Shimazu T. Increased neuropeptide Y content in the arcuato-paraventricular hypothalamic neuronal system in both insulin-dependent and non-insulin-dependent diabetic rats. Brain Res. 539:1991;223-227.
2. 1 antagonist BIBP3226. Br. J. Pharmacol. 116:1995;2245-2250.
3. Allen C.J., Ghilardi J.R., Vigna S.R., Mannon P.J., Taylor I.L., McVey D.C., Maggio J.E., Mantyh P.W. Neuropeptide Y/peptide YY receptor binding sites in the heart: localization and pharmacological characterization. Neuroscience. 53:1993;889-898.
4. J.J. Allen, J.I.E. Koenig (Eds.), Central and Peripheral significance of neuropeptide Y and its related peptides, Ann. N.Y. Acad. Sci. 611 (1992).
5. Allen J.M., Polak A.T., Bloom S.R. Neuropeptide Y in the adrenal gland. J. Autonom Nerv. Syst. 298:1983;240-244.
6. Allen J.M., Shon F., Todd N., Yeats J.C., Crockard H.A., Bloom S.R. Presence of neuropeptide Y in human circle of Willis, its possible role in cerebral vasospasm. Lancet. 2:1984;550-552.
7. Allen Y.S., Adrian T.E., Allen J.M., Tatemoto K., Crow T.J., Bloom S.R., Polak J.M. Neuropeptide Y distribution in rat brain. Science. 221:1983;877-879.
8. Anderson R.G.W. Caveolae: where incoming and outgoing messengers meet. Proc. Natl. Acad. Sci. USA. 90:1993;10909-10913.
9. Bai F.L., Yamano M., Shiotani Y., Emson P.C., Smithe A.D., Powell J.F., Tohyama M. An arcuato-paraventricular and -dorsomedial hypothalamic neuropeptide Y-containing system which lacks noradrenaline in the rat. Brain Res. 331:1985;172-175.
10. Baker R.A., Herkenham M. Arcuate nucleus neurons that project to the hypothalamic paraventricular nucleus: neuropeptidergic identity and consequences of adrenalectomy on mRNA levels in the rat. J. Comp. Neurol. 358:1995;518-530.
11. L. Bao, J. Kopp, X. Zhang, Z.-Q. Xu, L.-F. Zhang, H. Wong, J. Walsh, T. Hökfelt, Localization of neuropeptide Y Y1 receptors in cerebral blood vessels, Proc. Natl. Acad. Sci. 94 (1997) 12661-12666.
12. Beck B., Burlet A., Nicolas J.-P., Burlet C. Hypothalamic neuropeptide Y (NPY) in obese Zucker rats: implications in feeding and sexual behaviors. Physiol. Behav. 47:1990;449-453.
13. Bendotti C., Vezzani A., Serafini R., Servadio A., Rivolta R., Samanin R. Increased preproneuropeptide Y mRNA in the rat hippocampus during the development of hippocampal kindling: comparison with the expression of preprosomatostatin mRNA. Neurosci. Lett. 132:1991;175-178.
14. Bloch B., Bugnon C., Fellman D., Lenys D. Immunocytochemical evidence that the same neurons in the human infundibular nucleus are stained with anti-endorphins and antisera of other related peptides. Neurosci. Lett. 10:1978;147-152.
15. Bloom F., Battenberg E., Rossier J., Ling N., Guillemin R. Neurons containing beta-endorphin in rat brain exist separately from those containing enkephalin: immunocytochemical studies. Proc. Natl. Acad. Sci. USA. 75:1978;1591-1595.
16. Brady L.S., Smith M.A., Gold P.W., Herkenham M. Altered expression of hypothalamic neuropeptide mRNAs in food-restricted and food-deprived rats. Neuroendocrinology. 52:1990;441-447.
17. C. Broberger, J. Johansen, M. Schalling, T. Hökfelt, Hypothalamic neurohistochemistry of the murine anorexia (anx/anx) mutation: altered processing of neuropeptide Y (NPY) in the arcuate nucleus, J. Comp. Neurol. 387 (1997) 124-135.
18. C. Broberger, M. Landry, H. Wong, J. Walsh, T. Hökfelt, Neuropeptide Y Y1 and Y2 receptors are expressed in, respectively, POMC and neuropeptide Y neurons in the rat hypothalamic arcuate nucleus, Neuroendocrinology, (1997) in press.
19. Chronwall B.M., DiMaggio D.A., Massari V.J., Pickel V.M., Ruggiero D.A., O'Donohue T.L. The anatomy of neuropeptide Y-containing neurons in rat brain. Neuroscience. 15:1985;1159-1181.
20. Chua S.C., Brown A.W., Kim J., Hennessey K.L., Leibel R.L., Hirsch J. Food deprivation and hypothalamic neuropeptide gene expression: effects of strain background and the diabetes mutation. Mol. Brain Res. 11:1991;291-299.
21. Clark J.T., Kalra P.S., Crowley W.R., Kalra S.P. Neuropeptide Y and human pancreatic polypeptide stimulate feeding behavior in rats. Endocrinology. 115:1984;427-429.
22. Colmers W.F. Modulation of synaptic transmission in hippocampus by neuropeptide Y: presynaptic actions. Ann. N.Y. Acad. Sci. 611:1990;206-218.
23. W.F. Colmers, C.E. Wahlestedt, The Biology of Neuropeptide Y and Related Peptides, Humana Press, Ottawa, 1993.
24. Corness J., Shi T.-J., Xu Z.-Q., Brulet P., Hökfelt T. Influence of leukemia inhibitory factor on galanin/GMAP and neuropeptide Y expression in mouse primary sensory neurons after axotomy. Exp. Brain Res. 112:1996;79-88.
25. Cross A.J., Kimberlin R.H., Crow T.J., Johnson J.A., Walker C.A. Neurotransmitter metabolites, enzymes and receptors in experimental scrapie. J. Neurol. Sci. 70:1985;231-241.
26. Csiffáry A., Görcs T.J., Palkovits M. Neuropeptide Y innervation of ACTH-immunoreactive neurons in the arcuate nucleus of rats: a correlated light and electron microscopic double immunolabeling study. Brain Res. 506:1990;215-222.
27. de Quidt M.E., Emson P.C. Distribution of neuropeptide Y-like immunoreactivity in the rat central nervous system - II Immunohistochemical analysis. Neuroscience. 18:1986;545-618.
28. Diez M., Koistinaho J., DeArmond S.J., Camerino A.P., Groth D., Caytano J.C., Prusiner S., Hökfelt T. Abberrant induction of neuropeptide Y mRNA in hippocampus CA3 pyramidal neurones in scrapie-infected mice. NeuroReport. 7:1996;1887-1892.
29. M. Diez, J. Koistinaho, S.J. DeArmond, D. Groth, J.B. Prusiner, T. Hökfelt, Marked decrease of neuropeptide Y Y2 receptor binding sites in the hippocampus in murine prion disease, Eur. J. Neurosci. (1997) submitted.
30. Duggan A.W., Hope P.J., Lang C.W. Microinjection of neuropeptide Y into the superficial dorsal horn reduces stimulus-evoked release of immunoreactive substance P in the anesthetized cat. Neuroscience. 44:1991;733-740.
31. Durand-Gorde J.M., Bert J., Nieoullon A. Changes in tyrosine hydroxylase, glutamic acid decarboxylase and choline acetyltransferase after local microinoculation of scrapie agent into the nigrostriatal system of the golden hamster. Brain Res. 341:1985;243-251.
32. Edvinsson L., Emson P., McCulloch J., Tatemoto K., Uddman R. Neuropeptide Y: cerebrovascular innervation and vasomotor effects in the cat. Neurosci. Lett. 43:1983;79-84.
33. L. Edvinsson, E.T. MacKenzie, J. McCulloch, Cerebral Blood Flow, Metabolism, Raven Press, New York, 1993.
34. Ekblad E., Edvinsson L., Wahlestedt C., Uddman R., Håkanson R., Sundler F. Neuropeptide Y co-exists and co-operates with noradrenaline in perivascular nerve fibers. Reg. Peptides. 8:1984;225-235.
35. Ericsson A., Hemsén A., Lundberg J.M., Persson H. Detection of neuropeptide Y-like immunoreactivity and messenger RNA in rat platelets: the effects of vinblastine, reserpine, and dexamethasone on NPY expression in blood cells. Exp. Cell Res. 192:1991;604-611.
36. Ericsson A., Schalling M., McIntyre K., Lundberg J.M., Larhammar D., Seroogy K., Hökfelt T., Persson H. Detection of neuropeptide Y and its mRNA in megacaryocytes: enhanced levels in certain autoimmune mice. Proc. Natl. Acad. Sci. USA. 84:1987;5585-5589.
37. Euler U.S.v., Gaddum J.H. An unidentified depressor substance in certain tissue extracts. J. Physiol. (Lond.). 72:1931;74-87.
38. Eva C., Keinänen K., Monyer H., Seeburg P., Sprengel R. Molecular cloning of a novel G protein-coupled receptor that may belong to the neuropeptide receptor family. FEBS Lett. 271:1990;81-84.
39. Eva C., Oberto A., Sprengel R., Genazzani E. The murine NPY-1 receptor gene. Structure, delineation of tissue-specific expression. FEBS Lett. 314:1992;285-288.
40. Evans C.J., Keith D.E., Morrison H., Magendzo K., Edwards R.H. Cloning of a delta opioid receptor by functional expression. Science. 258:1992;1952-1955.
41. Everitt B.J., Hökfelt T., Terenius L., Tatemoto K., Mutt V., Goldstein M. Differential co-existence of neuropeptide Y (NPY)-like immunoreactivity with catecholamines in the central nervous system of the rat. Neuroscience. 11:1984;443-462.
42. Everitt B.J., Meister B., Hökfelt T., Melander T., Terenius L., Rökaeus Å., Theodorsson-Norheim E., Dockray G., Edwardson J., Cuello C., Elde R., Goldstein M., Hemmings H., Quimet C., Walaas I., Greengard P., Vale W., Weber E., Wu J.-Y., Chang K.-J. The hypothalamic arcuate nucleus-median eminence complex: immunohistochemistry of transmitters, peptides and DARPP-32 with special reference to coexistence in dopamine neurons. Brain Res. Rev. 11:1986;97-155.
43. Fuxe K., Tinner B., Caberlotto L., Bunnemann B., Agnati L.F. NPY Y1 receptor like immunoreactivity exists in a subpopulation of β-endorphin immunoreactive nerve cells in the arcuate nucleus: a double immunolabelling analysis in the rat. Neurosci. Lett. 225:1997;49-52.
44. Gehlert D.R., Beavers L.S., Johnson D., Gackenheimer S.L., Schober D.A., Gadski R.A. Expression cloning of human brain neuropeptide Y Y2 receptor. Mol. Pharmacol. 49:1996;224-228.
45. Gerald C., Walker M.W., Vaysse P.J.-J., He C., Branchek T.A., Weinshank R.L. Expression cloning and pharmacological characterization of a human hippocampal neuropeptide Y/peptide YY Y2 receptor subtype. J. Biol. Chem. 270:1995;26758-26761.
46. Ghilardi J.R., Allen C.J., Vigna S.R., McVey D.C., Mantyh P.W. Cholecystokinin and neuropeptide Y receptors on single rabbit vagal afferent ganglion neurons: site of prejunctional modulation of visceral sensory neurons. Brain Res. 633:1994;33-40.
47. Gibson J.J., Polak J.M., Allen J.M., Adrian T.E., Kelly J.S., Bloom S.R. The distribution and origin of a novel brain peptide, neuropeptide Y, in the spinal cord of several mammals. J. Comp. Neurol. 227:1984;78-91.
48. L. Grundemar, S.R.E. Bloom, Neuropeptide Y and Drug Development, Academic Press, New York, 1997.
49. Grundemar L., Håkanson R. Multiple neuropeptide Y receptors are involved in cardiovascular regulation. Peripheral and central mechanisms. General Pharmacol. 24:1993;785-796.
50. Gustafson E.L., Smith K.E., Durkin M.M., Walker M.W., Gerald C., Weinshank R., Branchek T.A. Distribution of the neuropeptide Y Y2 receptor mRNA in rat central nervous system. Mol. Brain Res. 46:1997;223-235.
51. Herzog H., Hort Y.J., Ball H.J., Hayes G., Shine J., Selbie L.A. Cloned human neuropeptide Y receptor couples to two different second messenger systems. Proc. Natl. Acad. Sci. USA. 89:1992;5794-5798.
52. Hökfelt T., Lundberg J.M., Terenius L., Jancso G., Kimmel J. Avian pancreatic polypeptide (APP) immunoreactive neurons in the spinal cord and spinal trigeminal nucleus. Peptides. 2:1981;82-87.
53. Hökfelt T., Wiesenfeld-Hallin Z., Villar M.J., Melander T. Increase of galanin-like immunoreactivity in rat dorsal root ganglion cells after peripheral axotomy. Neurosci. Lett. 83:1987;217-220.
54. Holets V.R., Hökfelt T., Rökaeus A., Terenius L., Goldstein M. Locus coeruleus neurons in the rat containing neuropeptide Y, tyrosine hydroxylase or galanin and their efferent projections to the spinal cord, cerebral cortex and hypothalamus. Neuroscience. 24:1988;893-906.
55. Hua X.Y., Boublik J.H., Spicer M.A., Rivier J.E., Brown M.R., Yaksh T.L. The antinociceptive effects of spinally administered neuropeptide Y in the rat: systematic studies on structure-activity relationship. J. Pharmacol. Exp. Ther. 258:1991;243-248.
56. Hughes J., Smith T.W., Kosterlitz H.W., Fothergill L.A., Morgan B.A., Morris H.R. Identification of two related pentapeptides from the brain with potent opiate agonist activity. Nature. 258:1975;577-580.
57. Hunt S.P., Emson P.C., Gilbert R., Goldstein M., Kimmel J.R. Presence of avian pancreatic polypeptide-like immunoreactivity in catecholamine and methionine-enkephalin containing neurons within the central nervous system. Neurosci. Lett. 21:1981;125-130.
58. 125I ] neuropeptide Y receptor binding sites in rat spinal cord and the effects of neonatal capsaicin, dorsal rhizotomy and peripheral axotomy Brain Res. 574:1992;333-337.
59. Kashiba H., Senba E., Ueda Y., Tohyama M. Co-localized but target-unrelated expression of vasoactive intestinal polypeptide and galanin in rat dorsal root ganglion neurons after peripheral nerve crush injury. Brain Res. 582:1992;47-57.
60. Kieffer B.L., Befort K., Gaveriaux-Ruff C., Hirth C.G. The δ-opioid receptor: isolation of a cDNA by expression cloning and pharmacological characterization. Proc. Natl. Acad. Sci. USA. 89:1992;12048-12052.
61. Kopp J., Zhang X., Hökfelt T. Neuropeptide Y1 receptors in the rat genital tract. Reg. Peptides. 70:1997;149-160.
62. Krause J., Eva C., Seeburg P.H., Sprengel R. Neuropeptide Y1 subtype pharmacology of a recombinantly expressed neuropeptide receptor. Mol. Pharmacol. 41:1992;817-821.
63. Larhammar D. Structural diversity of receptors for neuropeptide Y, peptide YY and pancreatic polypeptide. Reg. Peptides. 65:1996;165-174.
64. Larhammar D., Blomqvist A.G., Yee F., Jazin E., Yoo H., Wahlestedt C. Cloning and functional expression of a human neuropeptide Y/peptide YY receptor of the Y1 type. J. Biol. Chem. 267:1992;10935-10938.
65. Larsen P.J., Sheikh S.P., Jakobsen C.R., Schwartz T.W., Mikkelsen J.D. Regional distribution of putative NPY Y receptors and neurons expressing Y mRNA in forebrain areas of the rat central nervous system. Eur. J. Neurosci. 5:1993;1622-1637.
66. Lord J., Waterfield A., Hughes J., Kosterlitz H. Endogenous opioid peptides: multiple agonists and receptors. Nature. 267:1977;495-499.
67. Lu P., Sturman J.A., Bolton D.C. Altered GABA distribution in hamster brain is an early molecular consequence of infection by scrapie prions. Brain Res. 681:1995;235-241.
68. Lundberg J.M. Pharmacology of cotransmission in the autonomic nervous system: integrative aspects on amines, neuropeptides, adenosine triphosphate, amino acids and nitric oxide. Pharmacol. Rev. 48:1996;113-178.
69. Lundberg J.M., Martinsson A., Hemsén A., Theodorsson-Norheim E., Svedenhag J., Ekholm B., Hjemdahl P. Co-release of neuropeptide Y and catecholamines during physical exercise in man. Biochem. Biophys. Res. Commun. 133:1985;30-36.
70. Lundberg J.M., Tatemoto K. Pancreatic polypeptide family (APP, BPP, NPY and PYY) in relation to alpha-adrenoceptor-resistant sympathetic vasoconstriction. Acta Physiol. Scand. 116:1982;393-402.
71. Lundberg J.M., Terenius L., Hökfelt T., Goldstein M. High levels of neuropeptide Y in peripheral noradrenergic neurons in various mammals including man. Neurosci. Lett. 42:1983;167-172.
72. Maltais L.J., Lane P.W., Beamer W.G. Anorexia, a recessive mutation causing starvation in preweanling mice. J. Hered. 75:1984;468-472.
73. Marksteiner J., Lassmann H., Saria A., Humpel C., Meyer D.K., Sperk G. Neuropeptide levels after pentylenetetrazol kindling in the rat. Eur. J. Neurosci. 2:1990;98-103.
74. Masu Y., Nakayama K., Tamaki H., Harada Y., Kuno M., Nakanishi S. cDNA cloning of bovine substance-K receptor through oocyte expression system. Nature. 329:1987;836-838.
75. McKibbin P.E., Cotton S.J., McMillan S., Holloway B., Mayers R., McCarthy H.D., Williams G. Altered neuropeptide Y concentrations in specific hypothalamic regions of obese (fa/fa) Zucker rats. Possible relationship to obesity and neuroendocrine disturbances. Diabetes. 40:1991;1423-1429.
76. Meister B., Ceccatelli S., Hökfelt T., Andén N.-E., Theodorsson E. Neurotransmitters, neuropeptides and binding sites in the rat mediobasal hypothalamus: effects of monosodium glutamate (MSG) lesions. Exp. Brain Res. 76:1989;343-368.
77. W. Meyerhof, M.G. Darlison, D. Richter, The elucidation of neuropeptide receptors and their subtypes through the application of molecular biology, in: F. Hucho (Ed.), New Comprehensive Biochemistry, vol. 25, Elsevier, Amsterdam, 1993, pp. 335-353.
78. 2+. Biochem. Intern. 22:1990;205-212.
79. Montesano R., Roth J., Robert A., Orci L. Non-coated membrane invaginations are involved in binding and internalization of cholera and tetanus toxins. Nature. 296:1982;651-653.
80. V. Mutt, Chemical properties of some polypeptides affecting vascular function, in: A. Nobin, C. Owman, B. Arneklo-Nobin (Eds.), Neuronal Messengers in Vascular Function, Elsevier Science Publishers, Amsterdam, 1987, pp. 125-198.
81. V. Mutt, NPY: the background, in: V. Mutt, K. Fuxe, T. Hökfelt, J.M. Lundberg (Eds.), Neuropeptide Y. Karolinska Institute, Nobel Conferences Series, Raven Press, New York, 1989, pp. 1-12.
82. V. Mutt, K. Fuxe, T. Hökfelt, J.M.E. Lundberg (Eds.), Neuropeptide Y. Karolinska Institute Nobel Conference Series, Raven Press, New York, 1989.
83. 1 receptor mediating vasoconstriction in human cerebral arteries. Neurosci. Lett. 204:1996;145-148.
84. Noguchi K., De Leon M., Nahin R.L., Senba E., Ruda M.A. Quantification of axotomy-induced alteration of neuropeptide mRNAs in dorsal root ganglion neurons with special reference to neuropeptide Y mRNA and the effects of neonatal capsaicin treatment. J. Neurosci. 35:1994;54-66.
85. C. Owman, Autonomic innervation of the cardiovascular system, in: A. Björklund, T. Hökfelt, C. Owman (Eds.), Handbook of Chemical Neuroanatomy. The Peripheral Nervous system, vol. 6, Elsevier, Amsterdam, 1988, pp. 327-389.
86. Pernow B. Studies on substance P: purification, occurrence, and biological actions. Acta Physiol. Scand. 29 (Suppl. 105):1953;1-90.
87. Pernow J., Hemsén A., Hallén A., Lundberg J.M. Release of endothelin-like immunoreactivity in relation to neuropeptide Y and catecholamines during endotoxin shock and asphyxia in the pig. Acta Physiol. Scand. 140:1990;311-322.
88. Prusiner S.B. Genetic and infectious prion diseases. Arch. Neurol. 50:1993;1129-1153.
89. Raichle M.E., Hartman B.K., Eichling J.O., Sharpe L.G. Central noradrenergic regulation of cerebral blood flow and vascular permeability. Proc. Natl. Acad. Sci. USA. 72:1975;3726-3730.
90. Raposo G., Dunia I., Delavier-Klutchko C., Kaveri S., Strosberg A.D., Benedetti E.L. Internalization of β-adrenergic receptor in A431 cells involves non-coated vesicles. Eur. J. Cell Biol. 50:1989;340-352.
91. Rose P.M., Fernandes P., Lynch J.S., Fraxier S.T., Fisher S.M., Kodukula K., Kienzle B., Seethala R. Cloning and functional expression of a cDNA encoding a human type 2 neuropeptide Y receptor. J. Biol. Chem. 270:1995;22661-22664.
92. Sadamatsu M., Kanai H., Masui A., Serikawa T., Yamada J., Sasa M., Kato N. Altered brain contents of neuropeptides in spontaneously epileptic rats (SER) and tremor rats with absence seizures. Life Sci. 57:1995;523-531.
93. Sahu A., Kalra P.S., Kalra S.P. Food deprivation and ingestion induce reciprocal changes in neuropeptide Y concentrations in the paraventricular nucleus. Peptides. 9:1988;83-86.
94. Sanacora G., Kershaw M., Finkelstein J.A., White J.D. Increased hypothalamic content of preproneuropeptide Y messenger ribonucleic acid in genetically obese Zucker rats and its regulation by food deprivation. Endocrinology. 127:1990;730-737.
95. Schwartz T.W., U.G, Schambye H.T., Hjorth S.A. Molecular mechanism of action of non-peptide ligands for peptide receptors. Current Pharm. Design. 1:1995;325-342.
96. Shehab S.A., Atkinson M.E. Vasoactive intestinal polypeptide (VIP) increases in the spinal cord after peripheral axotomy of the sciatic nerve originate from primary afferent neurons. Brain Res. 372:1986;37-44.
97. Sheikh S.P., Roach E., Fuhlendorff J., Williams J.A. Localization of Y1 receptors for NPY and PYY on vascular smooth muscle cells in rat pancreas. Am. J. Physiol. 260:1991;G250-G257.
98. Sperk G., Marksteiner J., Gruber B., Bellmann R., Mahata M., Ortler M. Functional changes in neuropeptide Y - and somatostatin - containing neurons induced by limbic seizures in the rat. Neuroscience. 50:1992;831-846.
99. Stanley B.G., Leibowitz S.F. Neuropeptide Y injected in the paraventricular hypothalamus: a powerful stimulant of feeding behavior. Proc. Natl. Acad. Sci. USA. 82:1985;3940-3943.
100. Tatemoto K. Neuropeptide Y; complete amino acid sequence of the brain peptide. Proc. Natl. Acad. Sci. USA. 79:1982;5485-5489.
101. K. Tatemoto, Neuropeptide Y, Isolation, structure and function, in: V. Mutt, K. Fuxe, T. Hökfelt, J.M. Lundberg (Eds.), Neuropeptide Y. Karolinska Institute, Nobel Conferences Series, Raven Press, New York, 1989, pp. 13-21.
102. Tatemoto K., Carlquist M., Mutt V. Neuropeptide Y, a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide. Nature. 296:1982;659-660.
103. Tatemoto K., Mutt V. Isolation and characterization of the intestinal peptide porcine PHI (PHI127), a new member of the glucagon-secretin family. Proc. Natl. Acad. Sci. USA. 78:1981;6603-6607.
104. Tonder N., Kragh J., Finsen B.R., Bolwig T.G., Zimmer J. Kindling induces transient changes in neuronal expression of somatostatin, neuropeptide Y, and calbindin in adult rat hippocampus and fascia dentata. Epilepsia. 35:1994;1299-1308.
105. Vey M., Pilkuhn S., Wille H., Nixon R., DeArmond S.J., Smart E.J., Anderson R.G.W., Taraboulos A., Prusiner S.B. Subcellular colocalization of the cellular and scrapie prion proteins in caveolae-like membranous domains. Proc. Natl. Acad. Sci. USA. 93:1996;14945-14949.
106. Vezzani A., Civenni G., Rizzi M., Monno A., Messali S., Samanin R. Enhanced neuropeptide Y release in the hippocampus is associated with chronic seizure susceptibility in kainic acid treated rats. Brain Res. 660:1994;138-143.
107. Villar M.J., Cortés R., Theodorsson E., Wiesenfeld-Hallin Z., Schalling M., Fahrenkrug J., Emson P.C., Hökfelt T. Neuropeptide expression in rat dorsal root ganglion cells and spinal cord after peripheral nerve injury with special reference to galanin. Neuroscience. 33:1989;587-604.
108. Wahlestedt C., Yanaihara N., Håkanson R. Evidence for different pre- and post-junctional receptors for neuropeptide Y and related peptides. Reg. Peptides. 13:1986;307-318.
109. Wakisaka S., Kajander K.C., Bennett G.J. Increased neuropeptide (NPY)-like immunoreactivity in rat sensory neurons following peripheral axotomy. Neurosci. Lett. 124:1991;200-203.
110. Wakisaka S., Kajander K.C., Bennett G.J. Effects of peripheral nerve injuries and tissue inflammation on the levels of neuropeptide Y-like immunoreactivity in rat primary afferent neurons. Brain Res. 598:1992;349-352.
111. Wakisaka S., Takikita S., Sasaki Y., Kato J., Tabata M.J., Kurisu K. Cell size-specific appearance of neuropeptide Y in the trigeminal ganglion following peripheral axotomy of different branches of the mandibular nerve of the rat. Brain Res. 620:1993;347-350.
112. 2+ currents in rat sensory neurons. J. Neurosci. 8:1988;2438-2446.
113. Walker P., Grouzmann E., Burnier M., Waeber B. The role of neuropeptide Y in cardiovascular regulation. TIPS. 12:1991;111-115.
114. Watson S.J., Barchas J.D., Li C.H. Beta-lipoprotein: localization in cells and axons in rat brain by immunocytochemistry. Proc. Natl. Acad. Sci. USA. 74:1977;5155-5158.
115. White D.M., Mansfield K. Vasoactive intestinal polypeptide and neuropeptide Y act indirectly to increase neurite outgrowth of dissociated dorsal root ganglion cells. Neuroscience. 73:1996;881-887.
116. Wilding J.P.H., Gilbey S.G., Bailey C.J., Batt R.A.L., Williams G., Ghatei M.A., Bloom S.R. Increased neuropeptide-Y messenger ribonucleic acid (mRNA) and decreased neurotensin mRNA in the hypothalamus of the obese (ob/ob) mouse. Endocrinology. 132:1993;1939-1944.
117. Williams G., Shellard L., Lewis D.E., McKibbin P.E., McCarthy H.D., Koeslag D.G., Russell J.C. Hypothalamic neuropeptide Y disturbances in the obese (cp/cp) JCR:LA corpulent rat. Peptides. 13:1992;537-540.
118. W.D.J. Willis, R.E. Coggeshall, Sensory Mechanisms of the Spinal Cord, Plenum, 1991.
119. Xu X.-J., Wiesenfeld-Hallin Z., Villar M.J., Fahrenkrug J., Hökfelt T. On the role of galanin, substance P and other neuropeptides in primary sensory neurons of the rat: studies on spinal reflex excitability and peripheral axotomy. Eur. J. Neurosci. 2:1990;733-743.
120. 3H -opioid receptor labeling in mounted tissue sections Brain Res. 179:1979;255-270.
121. Zhang Q., Shi T.-J., Ji R.-R., Zhang Y.-T., Sundler F., Hannibal J., Fahrenkrug J., T.H Expression of pituitary adenylate cyclase-activating polypeptide in dorsal root ganglia following axotomy: time course and coexistence. Brain Res. 705:1995;149-155.
122. Zhang X., Bao L., Xu Z.-Q., Kopp J., Arvidsson U., Elde R., Hökfelt T. Localization of neuropeptide Y Y1 receptors in the rat nervous system with special reference to somatic receptors on small dorsal root ganglion neurons. Proc. Natl. Acad. Sci. USA. 91:1994;11738-11742.
123. Zhang X., Ji R.-R., Nilsson S., Villar M., Ubink R., Ju G., Wiesenfeld-Hallin Z., Hökfelt T. Neuropeptide Y and galanin binding sites in rat and monkey lumbar dorsal root ganglia and spinal cord and effect of peripheral axotomy. Eur. J. Neurosci. 7:1995;367-380.
124. Zhang X., Ju G., Elde R., Hökfelt T. Effect of peripheral nerve cut on neuropeptides in dorsal root ganglia and the spinal cord of monkey with special reference to galanin. J. Neurocytol. 22:1993;342-381.
125. Zhang X., Meister B., Elde R., Verge V.M.K., Terenius L., Hökfelt T. Large caliber primary afferent neurons projecting to the gracile nucleus express neuropeptide Y after sciatic nerve lesions: an immunohistochemical and in situ hybridization study in rats. Eur. J. Neurosci. 5:1993;1510-1519.
126. Zhang X., Nicholas A.P., Hökfelt T. Ultrastructural studies on peptides in the dorsal horn of the spinal cord. I. Co-existence of galanin with other peptides in primary afferents in normal rats. Neuroscience. 57:1993;365-384.
127. Zhang X., Shi T.-J., Holmberg K., Landry M., Huan W., Xiao H., Ju G., Hökfelt T. Expression and regulation of the neuropeptide Y Y2 receptor in sensory and autonomic ganglia. Proc. Natl. Acad. Sci. USA. 94:1997;729-734.
128. Zhang X., Wiesenfeld-Hallin Z., Hökfelt T. Effect of peripheral axotomy on expression of neuropeptide Y receptor mRNA in rat lumbar dorsal root ganglia. Eur. J. Neurosci. 6:1994;43-57.
129. Zhang X., Xu Z.-Q., Bao L., Dagerlind Å., Hökfelt T. Complementary distribution of receptors for neurotensin and NPY in small neurons in rat lumbar DRGs and regulation of the receptors and peptides after peripheral axotomy. J. Neurosci. 15:1995;2733-2747.
130. Zhang Y.-Z., Hannibal J., Zhao Q., Moller K., Danielsen N., Fahrenkrug J., Sundler F. Pituitary adenylate cyclase activating peptide (PACAP) expression in the rat dorsal root ganglia: up-regulation after peripheral nerve injury. Neuroscience. 74:1996;1099-1110.
131. Zukowska-Grojec Z., Dayao E.K., Karwatowska-Prokopczuk E., Hauser G.J., Doods H.N. Stress-induced mesenteric vasoconstriction in rats is mediated by neuropeptide Y Y1 receptors. Am. J. Physiol. 270:1996;H796-H800.
132. Zukowska-Grojec Z., Pruszczyk P., Colton C., Yao J., Shen G.H., Myers A.K., Wahlestedt C. Mitogenic effect of neuropeptide Y in rat vascular smooth muscle cells. Peptides. 14:1993;263-268.